Tozasertib lactate
(2S)-2-hydroxypropanoic acid;N-[4-[4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide
Molecular Identity
Tozasertib lactate
(2S)-2-hydroxypropanoic acid;N-[4-[4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide
PubChem CID: 44153236
2D Structure
Properties
C26H34N8O4S
Molecular Formula
554.70
Molecular Weight
g/mol
554.2424
Exact Mass
Da
185
TPSA
May have limited oral absorption
5
H-Bond Donors
11
H-Bond Acceptors
709
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Tozasertib lactateCN8EF9N084899827-04-4MK0457RefChem:190522Aurora Kinase Inhibitor MK-0457N-(4-((4-(4-methylpiperazin-1-yl)-6-((5-methyl-1H-pyrazol-3-yl)amino)pyrimidin-2-yl)sulfanyl)phenyl)cyclopropanecarboxamide lactateN-(4-((4-(4-methylpiperazin-1-yl)-6-((5-methyl-1H-pyrazol-3-yl)amino)pyrimidin-2-yl)sulfanyl)phenyl)cyclopropanecarboxamide, (2S)-2-hydroxypropanoateL-001281814Tozasertib lactate [USAN]VX-680 lactateTozasertib lactate (USAN)UNII-CN8EF9N084orb1741065CHEMBL2105657
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Tozasertib lactate
Loading drug network...